- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 383 Madison Avenue New York NY United States of America 10179
- IPO Date
- Apr 15, 2020
- Business
- JPMorgan BetaBuilders U.S. Mid Cap Equity ETF (BBMC) is an exchange-traded fund that seeks investment results corresponding to the performance of the Morningstar US Mid Cap Target Market Exposure Extended Index before fees and expenses; this rules-based, float-adjusted market capitalization-weighted index targets U.S. mid-cap equity securities falling between the 85th and 95th percentiles of the investable universe by float-adjusted market capitalization. The fund invests at least 80% of its assets in securities comprising the underlying index, employing a passive investment approach to replicate index performance; it offers investors diversified exposure across approximately 554 holdings spanning sectors such as industrials (22.2%), financials (15.6%), consumer discretionary (12.5%), information technology (14.2%), and health care (11.6%), with top holdings including Insmed Inc., SoFi Technologies Inc., and Comfort Systems USA Inc. Launched on April 14, 2020, BBMC is managed by J.P. Morgan Asset Management, part of JPMorgan Chase & Co., with a headquarters in Jersey City, New Jersey; it primarily serves U.S. investors targeting mid-cap blend strategies in the developed North American equity market.
As of late 2025, the fund maintains assets under management of approximately $1.96 billion, a gross and net expense ratio of 0.070%, and a trailing 12-month turnover ratio of 13%; it holds a Morningstar Silver Medalist Rating as of September 30, 2025, reflecting strong process, people, and parent pillars. Recent developments include the addition of Todd McEwen as portfolio manager effective March 1, 2025, complementing existing managers Michael Loeffler (28 years experience), Nicholas D'Eramo (28 years), and others; portfolio adjustments feature new positions in securities such as Credo Technology Group Holding Ltd, TechnipFMC plc, Hims & Hers Health Inc., Neurocrine Biosciences Inc., and Host Hotels & Resorts Inc., alongside increases in holdings like EMCOR Group Inc. and Comfort Systems USA Inc. The fund has delivered annualized returns of 15.46% since inception through September 30, 2025 (at NAV), with a 12-month rolling dividend yield of 1.40% as of October 31, 2025, amid steady AUM growth and quarterly rebalancing aligned with its benchmark.